Rhizen Pharmaceuticals S.A. Announces a Scientific Presentation on the PI3K-Delta Inhibitor, TGR-1202, at the XV International Workshop on Chronic Lymphocytic Leukemia at Cologne, Germany
9/9/2013 9:23:04 AM
La Chaux-de-Fonds, Switzerland, Sept. 9, 2013 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals announces a scientific poster presentation on the PI3K-delta inhibitor, TGR-1202, by the Duke University Medical Center, on 9th September 2013, at the IWCLL workshop in Cologne, Germany.
Help employers find you! Check out all the jobs and post your resume.
comments powered by